Panitumumab FDA Link

Recombinant human monoclonal antibody that binds to and inhibits the function of the EPIDERMAL GROWTH FACTOR RECEPTOR. It is used in the treatment of EGFR-expressing metastatic colorectal cancer that expresses wild-type ras gene (see GENES, RAS).

Also Known As:

Vectibix; ABX-EGF MAb; ABX-EGF Monoclonal Antibody; Panitumumab Antibody, Human; ABX EGF Monoclonal Antibody; Human Panitumumab Antibody; Monoclonal Antibody, ABX-EGF; Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        Panitumumab: 1101
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        Panitumumab: 1101
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        Panitumumab: 1101

A Desrichard Selected Research

A Desrichard Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure